期刊文献+

1例精神障碍患者的精准药学服务实践 被引量:1

Practice of precision pharmaceutical care for one patient with psychological disorder
下载PDF
导出
摘要 目的探讨临床药师在精神科开展精准药学服务的方法及其作用。方法与结果通过案例介绍临床药师借助药物基因检测以及寻找循证药学证据,为精神疾病患者提供个体化药学服务的过程,帮助药师和医生判断药物的不良反应和临床疗效,保证用药精准。结论精准药学服务可有效地为患者提供最佳的给药方案,促进合理用药。 Objective To explore the method and function of precision pharmaceutical care for clinical pharmacists in psychiatry department.Methods and Results This case report introduced the process of clinical pharmacists providing individualized pharmaceutical care for patients with mental illness by drug gene detection and evidence-based pharmaceutical evidence.It was helpful for pharmacists and doctors to judge the adverse reactions and clinical efficacy of drugs and ensure the accuracy of drugs.Conclusion Precision pharmaceutical care can effectively provide patients with the best drug delivery scheme and promote rational drug use.
作者 何佩华 娄元菊 徐伏莲 HE Peihua;LOU Yuanju;XU Fulian(The Third People s Hosptial of Jiangmen,Jiangmen 529000,China)
出处 《广东药科大学学报》 CAS 2019年第5期666-668,共3页 Journal of Guangdong Pharmaceutical University
关键词 精准药学 药学服务 精神障碍 precision pharmaceutical care pharmaceutical care psychological disorder
  • 相关文献

参考文献7

二级参考文献111

  • 1胡祥鹏,许建明,胡咏梅,梅俏,徐新华,徐叔云.CYP2C19基因多态性对奥美拉唑在中国人体内的药物动力学和药效学的影响[J].中国药理学通报,2005,21(10):1210-1213. 被引量:28
  • 2徐乐平,纪菊英,施辉,瞿发林,张斌,邵亚琴,孙剑.阿立哌唑治疗抗精神病药物所致高催乳素血症对照研究[J].中国行为医学科学,2006,15(8):718-720. 被引量:51
  • 3于欣,侯也之,舒良,王秀玲,李冰,刘卫红,林凯,杨顺才,宋丽华,廖安燕,谢家康,贾宏晓,张继志.利培酮治疗精神分裂症的开放性临床验证[J].中华精神科杂志,1997,30(2):79-82. 被引量:330
  • 4马玮亮,陆明康.抗精神病药引起女性闭经的调查[J].上海精神医学,2007,19(4):224-226. 被引量:19
  • 5Sallee FR, De Vane CL, FerreU RE. Fluoxefine-related death in a child with eytochrome P--450 2136 genetic deficiency [ J ]. J Child Adolesc Psychopharmaco1,2000,10 (1) :27-34.
  • 6McAlpine DE, O' Kane DJ, Black JL, et al. Cytochrome P4502D6 genotype variation and venlafaxine dosage[ J]. Mayo Clin Proc,2007,82(9) :1065-1068.
  • 7Ji Y, Biemacka JM, Hebbring S, et al. Pharmacogenomics of selective serotonin reuptake inhibitor treatment for major de- pressive disorder:genome-wide associations and functional ge- nomics[ J ]. Pharmacogenomics Journal, 2013,13 ( 5 ) : 456- 463.
  • 8Fudio S, Borobia AM, Piana E, et al. Evaluation of the influ- ence of sex and CYP2C19 and CYP2D6 polymorphisms in the disposition of citalopram [ J ]. Eur J Pharmacol, 2010,626 ( 2- 3 ) :200-204.
  • 9Hicks JK, Swen J J, Thorn CF, et al. Clinical pharmacogenetics implementation consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants [ J]. Clinical Pharmacology Therapeutics, 2013,93 ( 5 ) : 402- 408.
  • 10Ramasamy K, Narayan SK, Shewade DG, et al. Influence of CYP2C9 genetic polymorphism and under nourishment on plasma-free phenytoin concentrations in epileptic patients [ J ]. Ther Drug Monit,2010,32(6) :762-766.

共引文献59

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部